MDPI
+18
2673-5601
Monthly
2021
41616837734
YES
Switzerland
English
YES
Google Scholar
immuno@mdpi.com, jr-immuno@mdpi.com, ioana.craciun@mdpi.com
Immuno [ISSN 2673-5601] provides an advanced forum for studies related to basic and clinical immunology research. It publishes reviews, regular research papers, conference reports and communications as well as Special Issues on particular subjects. The aim of Immuno is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, the journal has no restrictions regarding the maximum length of papers. Full experimental details should be provided so that the results can be reproduced. We also encourage the publication of timely reviews and commentaries on topics of interest to the immunology community. Immuno requires authors to publish all experimental controls and make full datasets available where possible (see the guidelines on Supplementary Materials and references to unpublished data). Immuno accepts submissions that provide a thorough understanding of these areas, offering insights into the body's response to pathogens, artificial immune responses, molecular components, genetics, infectious diseases, cancer treatment, self-antigen response, developmental disorders, fertility, organ transplantation, skin interactions, mucosal tissues, nervous system interactions, disease analysis, and application of immunology in clinical settings. Innate immunity, Acquired immunity, Synthetic immunity, Structural immunology, Immunogenetics, Immunogenomics, Immunoproteomics, Immunometabolomics, Infectious immunology and vaccines, Cancer immunology, Immunotherapy, Autoimmunity and immunoregulation, Developmental immunology, Immunodeficiency, Reproductive immunology, Transplantation immunology, Immunodermatology, Mucosal immunology, Neuroimmunology, Immunopathology and immunohistology, Clinical/Translational immunology.
Advancements in sequencing and screening technology have made monoclonal antibodies more accessible, cost-effective, and precise. These drugs effectively target pathogens and cancer cells an...
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.